Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Keytruda
Pharma
Merck touts newly approved Winrevair as example of BD acumen
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the Keytruda LOE.
Kevin Dunleavy
Apr 25, 2024 11:06am
AACR: Detailed data spark hope for Merck combo in NSCLC
Apr 9, 2024 1:16pm
Merck’s Lynparza-Keytruda plan sputters in 2nd lung cancer trial
Mar 21, 2024 10:28am
Merck's Keytruda improves survival in cervical cancer trial
Mar 15, 2024 11:31am
GLP-1s on track to take drug sales throne from PD-1 inhibitors
Mar 15, 2024 10:54am
Merck claims digital crown, holding off challenge from AZ, BMS
Mar 15, 2024 10:30am